PFE.F

Pfizer Inc. operates as a global biopharmaceutical enterprise, dedicated to the discovery, development, production, marketing, and distribution of a wide array of medicinal and vaccine products across the globe. Its extensive portfolio addresses numerous therapeutic areas, including treatments for cardiovascular, metabolic, and women's health conditions, exemplified by brands such as the Premarin family and Eliquis. The company also develops a diverse range of biologics, small molecules, immunotherapies, and biosimilars, notably Ibrance, Xtandi, Sutent, and Braftovi. Furthermore, Pfizer offers sterile injectable medications, anti-infectives, and oral therapies for conditions like COVID-19, featuring brands such as Paxlovid, Zithromax, and Medrol. In the realm of vaccines, Pfizer is a key player, providing inoculations against major diseases including pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19, through products like Comirnaty/BNT162b2 and the Prevnar family. Its biosimilar offerings extend to chronic immune and inflammatory disorders, with examples like Xeljanz and Inflectra, while specialized treatments target amyloidosis, hemophilia, and endocrine diseases, including Vyndaqel/Vyndamax and Genotropin. Beyond its proprietary pharmaceuticals, Pfizer also engages in contract manufacturing services. Its customer base is broad, encompassing wholesalers, retail pharmacies, hospitals, clinics, government health organizations, individual medical practices, and disease control centers. Pfizer fosters strategic collaborations with various industry partners, including Bristol-Myers Squibb Company, BioNTech SE, and Astellas Pharma US, Inc. Established in 1849, Pfizer Inc. maintains its corporate headquarters in New York, New York.